[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100615019":3},{"organization":4,"armGroups":7,"interventions":22,"overallOfficials":41,"centralContacts":45,"locations":53,"responsibleParty":361,"collaborators":28,"id":363,"slug":364,"hasResults":365,"nctId":366,"briefTitle":367,"officialTitle":368,"acronym":369,"eligibilityCriteria":370,"healthyVolunteers":365,"sex":371,"minAge":372,"maxAge":28,"enrollmentInfo":373,"targetDuration":28,"studyType":376,"phases":377,"briefSummary":379,"conditions":380,"keywords":28,"overallStatus":56,"whyStopped":28,"lastUpdateSubmitDate":382,"lastUpdatePostDateStruct":383,"startDateStruct":386,"completionDateStruct":388,"leadSponsor":390,"locationsCount":391},{"fullName":5,"class":6},"Hoffmann-La Roche","INDUSTRY",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"Arm 1","EXPERIMENTAL","Participants will receive Inavolisib plus enzalutamide",[13,14],"Drug: Inavolisib","Drug: Enzalutamide",{"label":16,"type":17,"description":18,"interventionNames":19},"Arm 2","ACTIVE_COMPARATOR","Participants will receive either ARPi switch (enzalutamide or abiraterone) or docetaxel",[14,20,21],"Drug: Abiraterone","Drug: Docetaxel",[23,29,33,37],{"type":24,"name":25,"description":26,"armGroupLabels":27,"otherNames":28},"DRUG","Inavolisib","Inavolisib will be administered orally as per the schedule specified in the protocol.",[9],null,{"type":24,"name":30,"description":31,"armGroupLabels":32,"otherNames":28},"Enzalutamide","Enzalutamide will be administered orally as per the schedule specified in the protocol.",[9,16],{"type":24,"name":34,"description":35,"armGroupLabels":36,"otherNames":28},"Abiraterone","Abiraterone will be administered orally as per the schedule specified in the protocol.",[16],{"type":24,"name":38,"description":39,"armGroupLabels":40,"otherNames":28},"Docetaxel","Docetaxel will be administered intravenously as per the schedule specified in the protocol.",[16],[42],{"name":43,"affiliation":5,"role":44},"Clinical Trials","STUDY_DIRECTOR",[46,51],{"name":47,"role":48,"phone":49,"phoneExt":28,"email":50},"Reference Study ID Number: CO45813 https:\u002F\u002Fforpatients.roche.com\u002F","CONTACT","888-662-6728 (U.S. and Canada)","global-roche-genentech-trials@gene.com",{"name":52,"role":48,"phone":28,"phoneExt":28,"email":28},"Fastest response: use the inquiry form. No email attachments. https:\u002F\u002Fwww.gene.com\u002Fcontact-us\u002Fsubmit-medical-inquiry",[54,68,78,88,98,108,120,130,139,149,161,171,180,188,200,210,216,228,237,249,260,269,275,281,287,299,308,317,327,331,340,349],{"facility":55,"status":56,"city":57,"state":58,"zip":59,"country":60,"countryCode":61,"cosmosGeoPoint":62,"geoPoint":67,"contacts":28},"UCSF","RECRUITING","San Francisco","California","94115","United States","US",{"type":63,"coordinates":64},"Point",[65,66],-122.41942,37.77493,{"lat":66,"lon":65},{"facility":69,"status":56,"city":70,"state":71,"zip":72,"country":60,"countryCode":61,"cosmosGeoPoint":73,"geoPoint":77,"contacts":28},"Holden Comprehensive Cancer Center","Iowa City","Iowa","52242-1009",{"type":63,"coordinates":74},[75,76],-91.53017,41.66113,{"lat":76,"lon":75},{"facility":79,"status":56,"city":80,"state":81,"zip":82,"country":60,"countryCode":61,"cosmosGeoPoint":83,"geoPoint":87,"contacts":28},"Montefiore Einstein Cancer Center","The Bronx","New York","10461",{"type":63,"coordinates":84},[85,86],-73.86641,40.84985,{"lat":86,"lon":85},{"facility":89,"status":56,"city":90,"state":91,"zip":92,"country":60,"countryCode":61,"cosmosGeoPoint":93,"geoPoint":97,"contacts":28},"Lifespan Cancer Institute","Providence","Rhode Island","02903-4923",{"type":63,"coordinates":94},[95,96],-71.41283,41.82399,{"lat":96,"lon":95},{"facility":99,"status":56,"city":100,"state":101,"zip":102,"country":60,"countryCode":61,"cosmosGeoPoint":103,"geoPoint":107,"contacts":28},"Carolina Urologic Research Center","Myrtle Beach","South Carolina","29572-4607",{"type":63,"coordinates":104},[105,106],-78.88669,33.68906,{"lat":106,"lon":105},{"facility":109,"status":56,"city":110,"state":111,"zip":112,"country":113,"countryCode":114,"cosmosGeoPoint":115,"geoPoint":119,"contacts":28},"Royal North Shore Hospital-Pacific Hwy","St Leonards","New South Wales","2065","Australia","AU",{"type":63,"coordinates":116},[117,118],151.19836,-33.82344,{"lat":118,"lon":117},{"facility":121,"status":56,"city":122,"state":123,"zip":124,"country":113,"countryCode":114,"cosmosGeoPoint":125,"geoPoint":129,"contacts":28},"Sunshine Coast University Hospital","Birtinya","Queensland","4575",{"type":63,"coordinates":126},[127,128],153.11913,-26.74322,{"lat":128,"lon":127},{"facility":131,"status":56,"city":132,"state":123,"zip":133,"country":113,"countryCode":114,"cosmosGeoPoint":134,"geoPoint":138,"contacts":28},"Royal Brisbane & Womens Hospital","Herston","4006",{"type":63,"coordinates":135},[136,137],153.01852,-27.44453,{"lat":137,"lon":136},{"facility":140,"status":56,"city":141,"state":142,"zip":143,"country":113,"countryCode":114,"cosmosGeoPoint":144,"geoPoint":148,"contacts":28},"Box Hill Hospital","Box Hill","Victoria","3128",{"type":63,"coordinates":145},[146,147],145.12545,-37.81887,{"lat":147,"lon":146},{"facility":150,"status":56,"city":151,"state":152,"zip":153,"country":154,"countryCode":155,"cosmosGeoPoint":156,"geoPoint":160,"contacts":28},"Irmandade Da Santa Casa de Misericordia de Porto Alegre","Porto Alegre","Rio Grande do Sul","90035-074","Brazil","BR",{"type":63,"coordinates":157},[158,159],-51.23019,-30.03283,{"lat":159,"lon":158},{"facility":162,"status":56,"city":163,"state":164,"zip":165,"country":154,"countryCode":155,"cosmosGeoPoint":166,"geoPoint":170,"contacts":28},"CEPHO - Centro de Estudos e Pesquisas em Hematologia e Oncologia","Santo André","São Paulo","09060-650",{"type":63,"coordinates":167},[168,169],-46.53833,-23.66389,{"lat":169,"lon":168},{"facility":172,"status":56,"city":173,"state":164,"zip":174,"country":154,"countryCode":155,"cosmosGeoPoint":175,"geoPoint":179,"contacts":28},"Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto Hospital de Base - PPDS","São José do Rio Preto","15090-000",{"type":63,"coordinates":176},[177,178],-49.37944,-20.81972,{"lat":178,"lon":177},{"facility":181,"status":56,"city":164,"state":28,"zip":182,"country":154,"countryCode":155,"cosmosGeoPoint":183,"geoPoint":187,"contacts":28},"Instituto Do Câncer Do Estado de São Paulo Octávio Frias de Oliveira - ICESP","01246-000",{"type":63,"coordinates":184},[185,186],-46.63611,-23.5475,{"lat":186,"lon":185},{"facility":189,"status":56,"city":190,"state":191,"zip":192,"country":193,"countryCode":194,"cosmosGeoPoint":195,"geoPoint":199,"contacts":28},"Princess Margaret Cancer Centre","Toronto","Ontario","M5G 2M9","Canada","CA",{"type":63,"coordinates":196},[197,198],-79.39864,43.70643,{"lat":198,"lon":197},{"facility":201,"status":56,"city":202,"state":203,"zip":204,"country":193,"countryCode":194,"cosmosGeoPoint":205,"geoPoint":209,"contacts":28},"Centre de recherche du Centre Hospitalier de l'Universite de Montreal","Montreal","Quebec","H2X 0A9",{"type":63,"coordinates":206},[207,208],-73.58781,45.50884,{"lat":208,"lon":207},{"facility":211,"status":56,"city":202,"state":203,"zip":212,"country":193,"countryCode":194,"cosmosGeoPoint":213,"geoPoint":215,"contacts":28},"Jewish General Hospital","H3T 1E2",{"type":63,"coordinates":214},[207,208],{"lat":208,"lon":207},{"facility":217,"status":56,"city":218,"state":219,"zip":220,"country":221,"countryCode":222,"cosmosGeoPoint":223,"geoPoint":227,"contacts":28},"EDOG - Institut Bergonie - PPDS","Bordeaux","Gironde","33000","France","FR",{"type":63,"coordinates":224},[225,226],-0.58046,44.84124,{"lat":226,"lon":225},{"facility":229,"status":56,"city":230,"state":28,"zip":231,"country":221,"countryCode":222,"cosmosGeoPoint":232,"geoPoint":236,"contacts":28},"Centre Léon Bérard","Lyon","69008",{"type":63,"coordinates":233},[234,235],4.84789,45.74906,{"lat":235,"lon":234},{"facility":238,"status":56,"city":239,"state":240,"zip":241,"country":242,"countryCode":243,"cosmosGeoPoint":244,"geoPoint":248,"contacts":28},"Istituti Fisioterapici Ospitalieri","Rome","Lazio","00144","Italy","IT",{"type":63,"coordinates":245},[246,247],12.51133,41.89193,{"lat":247,"lon":246},{"facility":250,"status":56,"city":251,"state":252,"zip":253,"country":254,"countryCode":28,"cosmosGeoPoint":255,"geoPoint":259,"contacts":28},"Seoul National University Bundang Hospital","Seongnam-si","Gyeonggido","13620","South Korea",{"type":63,"coordinates":256},[257,258],127.13778,37.43861,{"lat":258,"lon":257},{"facility":261,"status":56,"city":262,"state":28,"zip":263,"country":254,"countryCode":28,"cosmosGeoPoint":264,"geoPoint":268,"contacts":28},"Seoul National University Hospital","Seoul","03080",{"type":63,"coordinates":265},[266,267],126.9784,37.566,{"lat":267,"lon":266},{"facility":270,"status":56,"city":262,"state":28,"zip":271,"country":254,"countryCode":28,"cosmosGeoPoint":272,"geoPoint":274,"contacts":28},"Severance Hospital, Yonsei University Health System","03722",{"type":63,"coordinates":273},[266,267],{"lat":267,"lon":266},{"facility":276,"status":56,"city":262,"state":28,"zip":277,"country":254,"countryCode":28,"cosmosGeoPoint":278,"geoPoint":280,"contacts":28},"Asan Medical Center.","05505",{"type":63,"coordinates":279},[266,267],{"lat":267,"lon":266},{"facility":282,"status":56,"city":262,"state":28,"zip":283,"country":254,"countryCode":28,"cosmosGeoPoint":284,"geoPoint":286,"contacts":28},"Samsung Medical Center","06351",{"type":63,"coordinates":285},[266,267],{"lat":267,"lon":266},{"facility":288,"status":56,"city":289,"state":290,"zip":291,"country":292,"countryCode":293,"cosmosGeoPoint":294,"geoPoint":298,"contacts":28},"Hospital Universitario Cruces","Barakaldo","Vizcaya","48903","Spain","ES",{"type":63,"coordinates":295},[296,297],-2.98813,43.29639,{"lat":297,"lon":296},{"facility":300,"status":56,"city":301,"state":28,"zip":302,"country":292,"countryCode":293,"cosmosGeoPoint":303,"geoPoint":307,"contacts":28},"C.H. Regional Reina Sofia - PPDS","Córdoba","14004",{"type":63,"coordinates":304},[305,306],-4.77275,37.89155,{"lat":306,"lon":305},{"facility":309,"status":56,"city":310,"state":28,"zip":311,"country":292,"countryCode":293,"cosmosGeoPoint":312,"geoPoint":316,"contacts":28},"Hospital Universitario 12 de Octubre","Madrid","28041",{"type":63,"coordinates":313},[314,315],-3.70256,40.4165,{"lat":315,"lon":314},{"facility":318,"status":56,"city":319,"state":28,"zip":320,"country":321,"countryCode":28,"cosmosGeoPoint":322,"geoPoint":326,"contacts":28},"Ankara Universitesi Tip Fakultesi Hastaneleri - Cebeci Hastanesi","Ankara","6590","Turkey (Türkiye)",{"type":63,"coordinates":323},[324,325],32.85427,39.91987,{"lat":325,"lon":324},{"facility":328,"status":56,"city":329,"state":28,"zip":330,"country":321,"countryCode":28,"cosmosGeoPoint":28,"geoPoint":28,"contacts":28},"VM Medical Park Samsun Hastanesi","Atakum","55200",{"facility":332,"status":56,"city":333,"state":28,"zip":334,"country":321,"countryCode":28,"cosmosGeoPoint":335,"geoPoint":339,"contacts":28},"Koc Universitesi Hastanesi","Istanbul","41380",{"type":63,"coordinates":336},[337,338],28.94966,41.01384,{"lat":338,"lon":337},{"facility":341,"status":56,"city":342,"state":28,"zip":343,"country":321,"countryCode":28,"cosmosGeoPoint":344,"geoPoint":348,"contacts":28},"Izmir Medical Point Hospital","Izmir","35101",{"type":63,"coordinates":345},[346,347],27.13838,38.41273,{"lat":347,"lon":346},{"facility":350,"status":56,"city":351,"state":352,"zip":353,"country":354,"countryCode":355,"cosmosGeoPoint":356,"geoPoint":360,"contacts":28},"The Royal Marsden in Sutton, Surrey - Downs Rd","Sutton","Surrey","SM2 5PT","United Kingdom","UK",{"type":63,"coordinates":357},[358,359],-0.2,51.35,{"lat":359,"lon":358},{"type":362,"investigatorFullName":28,"investigatorTitle":28,"investigatorAffiliation":28,"oldNameTitle":28,"oldOrganization":28},"SPONSOR","100615019","phase-2-a-study-to-test-inavolisib-treatment-in-participants-with-metastatic-castration-resistant-prostate-cancer-100615019",false,"NCT07287150","A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer","A Phase II, Randomized, Multicenter, Open-Label Study Evaluating the Efficacy and Safety of the Combination of Inavolisib Plus Enzalutamide Versus Physician's Choice of ARPI or Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer","InavoPC","Inclusion Criteria:\n\n* Histologically or cytologically confirmed adenocarcinoma of the prostate without small-cell or neuroendocrine features\n* Progressive metastatic CRPC, defined as any of the following: PSA progression, defined by a minimum of two rising PSA values from three consecutive assessments with an interval of at least 7 days between assessments and with a minimal starting value of PSA \\>=1 ng\u002FmL; The most recent qualifying PSA value must be determined within 14 days of enrollment; Soft tissue disease progression, defined by Response Evaluation Criteria in Solid Tumors, Version 1.1 (RECIST v1.1); Bone disease progression, defined by PCWG3 criteria, with two or more new metastatic bone lesions on a whole-body radionuclide bone scan\n* Treatment with at least one, but no more than one, prior second-generation ARPi (abiraterone, apalutamide, enzalutamide, darolutamide) for hormone- sensitive prostate cancer (HSPC) or CRPC\n* Availability of a tumor tissue specimen that is suitable (e.g., adequate quality and quantity) for use in determining biomarker status\n* Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1\n* Fasting glucose \\\u003C100 mg\u002FdL and HbA1c \\\u003C 5.7%\n\nExclusion Criteria:\n\n* Presence of liver metastasis\n* Prior treatment with any phosphatidylinositol-3-kinase (PI3K), protein kinase B (AKT), or mammalian target of rapamycin (mTOR) inhibitor, or with any agent with a mechanism of action of inhibiting the PI3K\u002FAKT\u002FmTOR pathway\n* Type 1 or Type 2 diabetes mellitus\n* Prior treatment for mCRPC with cytotoxic chemotherapy or novel hormonal treatments (e.g., androgen receptor degraders, CYP11 inhibitors), with the following treatments permitted: Prior docetaxel in mHSPC, providing no evidence of disease progression occurred during treatment or within 6 months of treatment completion; Prior docetaxel in the adjuvant or neoadjuvant setting providing no evidence of disease progression occurred during treatment or within 12 months of treatment completion; Prior treatment with sipuleucel-T, with the last dose administered \\>28 days prior to start of treatment; Prior PARPi therapy, as per local prescribing information, with the last dose administered \\>14 days prior to start of treatment; One prior RLT or radiotherapeutic agent (e.g., PSMA-targeted RLT, Radium 223) with the last dose administered \\>8 weeks prior to start of treatment\n* Other concurrent anti-cancer therapy except for androgen deprivation therapy\n* Treatment with strong CYP2C8 inhibitors, strong or moderate CYP2C8 inducers, or strong CYP3A4 inducers within 1 week or 5 drug-elimination half-lives, whichever is longer, prior to initiation of study treatment\n* Transfusion of any blood product for the sole purpose of making a potential participant eligible for study inclusion or within 28 days of enrollment","MALE","18 Years",{"count":374,"type":375},100,"ESTIMATED","INTERVENTIONAL",[378],"PHASE2","This study will evaluate the efficacy and safety of the combination of inavolisib plus enzalutamide compared with physician's choice of alternative androgen receptor pathway inhibitor (ARPi) or docetaxel in biomarker-selected participants with metastatic castrate-resistant prostate cancer (mCRPC) who have received one prior second-generation ARPi.",[381],"Metastatic Castration-Resistant Prostate Cancer","2026-06-03",{"date":384,"type":385},"2026-06-04","ACTUAL",{"date":387,"type":385},"2026-03-11",{"date":389,"type":375},"2029-07-30",{"name":5,"class":6},32]